Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- Check4 days agoChange DetectedA new revision entry (v3.3.3) was added to the record history, and an older revision (v3.3.2) along with the HHS Vulnerability Disclosure footer link were removed; these are metadata updates to the record history and do not affect the study's data or outcomes.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision tag (v3.3.2) was added to the record history, replacing the previous v3.2.0. This is a metadata update and does not change study details or results.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the notice about lapse in government funding and NIH operating status from the page.SummaryDifference0.7%

- Check54 days agoChange DetectedVersion 10 (2024-11-15) updates the record with revised Study Status and adds Outcome Measures, Baseline Characteristics, and Adverse Events sections to the study record.SummaryDifference0.1%

- Check83 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference12%

- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.